• Tidak ada hasil yang ditemukan

1 Intensive care and organ support related mortality in patients with COVID-19: A

N/A
N/A
Protected

Academic year: 2024

Membagikan "1 Intensive care and organ support related mortality in patients with COVID-19: A "

Copied!
17
0
0

Teks penuh

(1)

1 Intensive care and organ support related mortality in patients with COVID-19: A

systematic review and meta-analysis

Abhimanyu Chandel, MD

1

; Sahar Leazer, MD

2,3

; Karl C. Alcover, PhD

2

; Josiah Farley, BS

2

; Joshua Berk, BS

2

; Christopher Jayne, BS

2

; Ryan Mcnutt, BS

2

; Meredith Olsen, MD

1

; Rhonda Allard, MLIS

2

; Jiahong Yang, BS

2

; Ananya Tripathi, BS

2

; Maria Rechtin, MD

1

; Mathew Leon, MMSc

2

; Mathias Williams, MD

1

; Phorum Sheth, MPH

2

; Kyle Messer, DO

1

; Kevin K Chung, MD

2

; Jacob Collen, MD

1,2

1

Department of Pulmonary and Critical Care Medicine, Walter Reed National Medical Center, Bethesda, MD

2

Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD

3

The Metis Foundation, San Antonio, TX

Supplementary material

Table of Contents: Page number

Table S1………...……….2

Table S2………9

Table S3………9

Table S4………9

Table S4………...10

Figure S1………..11

Figure S2………..12

Figure S3………..13

Figure S4………..14

Figure S5………..15

Figure S6………..16

Figure S7………..17

(2)

2 Table S1: List and description of all included studies (9-159)

First Author Country Follow up

Complete In-hospital

Death ICU Death ECMO

Death RRT

Death MV Death Quality Score

Cao China Yes 17/102

(17.0%) 6/18

(33.0%) 1/3

(33.0%) 5/6

(83.0%) 12/14

(8.1%) 7

Yang China No 15/200

(7.5%) 14/29

(48.3%) - - - 5

Huang China No 0/202

(0.0%) 0/11

(0.0%) - - - 6

Wang China No 0/275

(0.0%) 0/29

(0.0%) - 0/6

(0.0%) 0/11

(0.0%) 5

Zhang China No 12/221

(5.4%) 9/44

(20.5%) - - - 5

Feng China No 38/476

(8.0%) 2970

(41.4%) - - - 3

Lei China Yes 1/297

(0.3%) 1/36

(2.8%) - - - 8

Feng China No 9/114

(8.0%) 20/29

(69.0%) 6/6

(100.0%) 2/2

(100.0%) 18/22

(81.8%) 6

Wang China No 133/344

(38.7%) 133/344

(38.7%) - - 97/100

(97%) 7

Guo China No 329/733

(50.7%) 329/733

(50.7%) - - - 6

Liu China Yes 157/1190

(13.2%) 157/349

(13.2%) 4/4

(100.0%) 4/4

(100.0%) 36/42

(85.7) 8

Chen China No 50/192

(26.0%) 50/192

(26.0%) - - - 8

Richards-

Belle United

Kingdom No 101/200

(50.5%) 90/200

(45.0%) - - - 5

Berenguer Spain No 1131/4035

(28.0%) 312/736

(42.4%) 10/18

(55.6%) 80/119

(67.2%) 283/619

(25.3) 8

Grasselli Italy No 405/1581

(26.0%) 405/1581

(26.0%) - - - 6

Oliveira United

States No 26/131

(19.8%) 26/131

(19.8%) 1/9

(11.1%) 15/24

(62.5%) 26/109

(23.9%) 8

Shahriarirad Iran No 9/113

(8%) 5/11

(55.6%) - - - 8

Suleyman United

States Yes 72/355

(20.3%) 57/141

(40.4%) - - - 7

Kaeuffer France No 115/1045

(11.0%) 26/355

(9.6%) - - - 4

Alharthy Saudi Arabia No 113/352

(32.1%) 113/352

(32.1%) - - 86/200

(43.0%) 6

Fleuren The

Netherlands No 853/3549

(29.4%) -

(24.4%) - - - 4

Fleuren The

Netherlands Yes 332/1152

(28.8%) 332/1152

(28.8%) - - - 7

Khan Saudi Arabia Yes 12/648

(1.8%) 12/77

(0.1%) - - - 8

Martinot France Yes 115/600

(19.1%) 44/153

(7.3%) - - - 8

Bidari Iran No 107/590

(18.2%) 107/186

(57.5%) - - - 7

(3)

3

Michela Netherlands No 210/553

(38.0%) 210/553

(38.0%) - - - 5

Cummings United

States Yes 101/257

(39.0%) 101/257

(39.0%) - - 151/203

(74.4%) 8

Zhou China No 82/195

(42.1%) -

(33%) 5/16

(31.3%) -

(50.0%) 56/97

(58.0%) 5

Argenziano USA No 211/850

(21.1%) 103/236

(43.6%) - - 111/233

(%47.6) 7

Kim South Korea Yes 47/110

(42.7%) 47/110

(42.7%) 8/19

(42.1%) 14/21

(73.7%) 36/79

(45.57%) 8 Mukherjee United

States No 82/137

(59.9%) 82/137

(59.9%) - - - 6

Filardo United

States No 78/270

(28.9%) 72/135

(53.3%) - 36/55

(65.5%) 67/121

(55.4%) 6

Gayam USA Yes 132/408

(33.4%) 78/117

(59.1%) - - 92/117

(69.7%) 7

Chand United

States NA 106/300

(67.5%) 106/300

(67.5%) - 82/117

(61.7%) - 7

Turcotte United

States No 29/117

(24.8%) 17/36

(47.2%) - - - 7

Kocayigit Turkey No 52/103

(50.0%) 52/103

(50.0%) - - 47/62

(75.8%) 6

Chen China No - 45/135

(33.3%) - - - 6

Janz United

States No 71/147

(48.3%) 71/147

(48.3%) - - - 4

Mitra Canada No 18/117

(15.4%) 18/117

(15.4%) - 6/16

(37.5%) 15/74

(20.3%) 4

El-Jawahri United

States Yes 118/470

(25.1%) 74/178

(62.7%) - - 73/150

(61.9%) 6

Guisado-

Vasco Spain Yes 141/607

(23.2%) 24/49

(49.0%) - - - 7

Omrani Qatar No 12/1424

(0.8%) 12/108

(11.1%) - - 12/91

(13.2%) 5

Docherty United

Kingdom No 5165/20133

(26.0%) 958/3001

(32.0%) - - - 8

Bonnet France No 360/2878

(12.5%) 74/475

(15.6%) - - - 6

Capone United

States No 61/102

(59.8%) 61/102

(59.8%) - 12/19

(63.2%) - 8

Larsson Sweden No 60/260

(23.1%) 60/260

(23.1%) - - - 6

Cedano United

States Yes - 92/132

(69.7%) - - - 8

Temel Turkey No NA 16/53

(34.0%) NA NA NA 5

Carrilo-Vega Mexico No 868/3922

(22.13%) 294/486

(60.5%) - - 234/460

(50.9%) 7

Israelsen Denmark Yes 43/175

(24.6%) 16/27

(59.3%) - - 17/27

(59.3%) 6

Azoulay France Yes 97/379

(25.8%) 97/379

(25.8%) - - - 7

Alser USA No 58/235

(24.7%) 58/235

(24.7%) - - - 7

(4)

4

Boscolo Italy Yes 120/280

(43.0%) 120/280

(43.0%) - - 120/280

(43.0%) 8

Wendel

Garcia Europe (Switzerland,

France, Netherlands,

Spain)

No 97/639

(15.2%) 97/639

(15.2% 4/11

(36.4%) 20/54

(37.0%) 58/317

(59.8%) 7

Akhter Pakistan - 22/100

(22.0%) 19/33

(58.0%) - - - 6

Ayde Kuwait Yes 47/103

(45.6%) 47/103

(45.6%) 2/9

(22%) 19/28

(67.9%) 47/79

(59.5) 7

Bastug Turkey Yes 20/191

(10.5%) 20/46

(43.5%) - - - 8

Ñamendys-

Silva Mexico Yes 85/164

(51.8%) 85/164

(51.8%) - 13/24

(54.1%) 85/164

(51.8%) 8

Peñuelas Spain Yes 335/868

(38.6%) 335/868

(38.6%) - - - 8

Cheng China Yes 133/168

(79.2%) 133/168

(79.2%) 53/74

(71.6) - - 7

Serrano-

Martinez Spain No - 0/59

(33.9%) - - 23/49

(46.7%) 7

Kim United

States Yes 420/2491

(17.0%) 299/798

(12.0%) - - 246/462

(53.0%) 8

Chew Sweden No 361/1563

(23.1%) 361/1563

(23.1%) - 121/271

(44.6%) 368/1222

(30.1%) 6

Magunia Germany Yes 403/1186

(34.0%) 403/1146

(34.0%) - - 217/495

(43.8%) 8

Bhargava United

States Yes 122/419

(29.1%) 75/101

(74.3%) - 16/21

(76.0%) - 7

Chew (e) Sweden Yes 361/1563

(23.0%) 361/1563

(23.0%) - - - 7

Thomson England No - 38/156

(24.0%) - - - 5

Chen China Yes - 181/228

(79.4%) 3/4

(75.0%) 37/39

(94.9%) 90/103

(87.4%) 7

Hernandez-

Romieu United

States Yes 56/430

(24.2%) 56/284

(24.2%) - - 63/175

(36.0%) 8

Rieg Germany Yes 51/213

(23.0%) 23/33

(47.0%) 14/23

(60.9%) 14/26

(53.8%) 29/57

(50.9%) 8

Chaudhary United

States Yes 80/120

(63.0%) 80/120

(63.0%) 3/6

(50.0%) 25/35

(71.4%) 4/12

(33.3%) 8

De Souza India Yes 156/689

(22.6%) 7/19

(36.8%) - - - 8

Rodríguez Spain Yes 660/2022

(32.6%) 660/2022

(32.6%) - - 458/1174

(39.0%) 8

Goshayeshi Iran Yes 353/1278

(27.6%) 70/151

(46.3%) - - - 8

Dosi Central India Yes 31/329

(9.42%) 31/83

(37.34%) - - - 8

Guglielmetti Italy No 100/218

(46.0%) 33/64

(51.6%) - - - 6

Rodrigo Brazil No 153/506

(30.2%) 135/300

(88.0%) - 7/9

(77.0%) 127/227

(56.0%) 5

Chew (b) Finland Yes 31/192

(16.0%) 31/192

(16.0%) - - - 7

(5)

5

Chew (a) Denmark Yes 118/383

(37.0%) 118/383

(33.0%) - - - 6

Haase Denmark No

(33.4%) (33.4%) -

(65.0%) - 6

ElAidaoui Morocco Yes NA 14/45

(31.1%) - - 11/14

(78%) 8

Yang Canada No 21/106

(19.8%) 21/106

(19.8%) - - 12/65

(18.5%) 5

Camporota England No 7/213

(34.0%) 7/213

(34.0%) - - 7/213

(34.0%) 6

Ferrando Spain Yes 203/663

(31.0%) 203/663

(31.0%) 9/15

(60.0%) 42/60

(70.0%) 182/494

(36.8%) 6

Ahlstrom Sweden No 346/1981

(18.0%) 346/1981

(18.0%) - - - 6

Estella Spain Yes 152/422

(36.5%) 152/422

(36.5%) - - 146/422

(34.6%) 8

Grasselli Italy No 1769/3988

(44.3%) 1769/3988

44.3%) 40/54

(62.5%) - 1514/2929

(51.7%) 7

Gadhiya United

States No 55/283

(19.4%) 42/89

(47.2%) 2/2

(100%) 13/16

(81.3%) 33/58

(56.9%) 6

Mekolo Cameroon Yes 91/282

(32.0%) 38/91

(42.0%) - - 5/6

(83.0%) 6

Zanella Italy No 126/1260

(33.8%) 426/1260

(33.8%) - - 272/707

(38.5%) 8

Rodriguez-

Gonzalez Spain No 268/1255

(21.4%) 52/126

(41.3%) 1/1

(100.0%) 1/1

(100.0%) 47/113

(41.6%) 6

Vahedi Iran Yes 77/133

(57.9%) 77/133

(57.9%) - - - 8

Roedl Germany Yes 78/223

(35.0%) 78/223

(35.0%) 13/20

(65.0%) 46/73

(63.0%) 74/167

(44.3%) 8

Cheng England Yes 594/1946

(30.5%) 211/98

(46.4%) - - - 6

Nasir Pakistan Yes 58/445

(13.0%) 40/68

(58.8%) - - 36/64

(56.3%) 8

Nachtigall Germany No 317/1904

(16.6%) 109/399

(27.0%) - - 77/250

(30.8%) 4

Bhargava United

States Yes 172/565

(43.8%) 106/140

(75.7%) - 18/24

(75.0%) - 8

Laake Norway Yes 40/217

(18.4%) 40/217

(18.4%) - 17/32

(53.1%) 38/187

(20.3%) 8

Ferrando-

Vivas England, Wales, Northern

Ireland

No 3933/9990

(39.4%) 3933/9990

(39.4%) - - - 6

Campanile Italy Yes 55/806

(7%) 55/806

(7%) - - - 8

Kayina India No 20/235

(8.5%) 20/235

(8.5%) - - - 6

AlMutair Saudi Arabia NA 614/1470

(41.8%) 614/1470

(41.8%) - - 51/71

(71.8%) 6

Altunal Turkey NA 33/143

(23.1%) 33/39

(84.6%) - - - 6

Burrell Australia No 30/204

(15.0%) 30/204

(15.0%) - 8/23

(32.0%) 26/119

(22.0%) 8

(6)

6

Chew (d) Norway Yes 46/224

(21.0%) 46/224

(21.0%) NA NA NA 7

Galindo Colombia Yes 85/377

(22.6%) 73/158

(46.2%) - - 73/153

(59.4%) 6

Khan

Chachar Pakistan Yes 37/445

(8.3%) 37/137

(27.0%) - 37/38

(97.37%) 37/40

(92.5%) 8

Roger France Yes 35/140

(18.0%) 35/140

(18.0%) 20/63

(31.7%) 67/136

(49.0%) 143/719

(19.9%) 8

Donamou Guinea Yes 35/140

(25%) 35/140

(25%) - - - 6

Alvarez-

Maldonado Mexico No 58/100

(58.0%) 58/100

(58.0%) - - - 6

Jalili Iran Yes 57/512

(11.1%) 56/125

(44.8) - - - 8

Alkaabi United Arab

Emirates No 196/1542

(12.7%) 196/1542

(12.7%) - - 167/519

(32.0%) 6

Nassar Egypt Yes 39/160

(24.4%) 39/160

(24.4%) 2/2

(100.0%) 10/14

(71.4%) 37/44

(84.0%) 8

Beatty Ireland Yes 677/4086

(16.6%) 105/521

(20.2%) - - - 8

Nachega Democratic Republic of the Congo

Yes 101/766

(14.3%) 86/191

(45.0%) - - - 7

Saha Bangladesh No - 95/168

(56.5%) - - - 8

De Souza Brazil Yes 66896/162045

(41.3%) 35634/57103

(62.4%) - - 28145/33916

(82.98%) 8 Ñamendys-

Silva Mexico Yes 8861/12018

(73.7%) 3647/5090

(71.7%) - - 8861/12018

(73.7%) 8

Alghamdi Saudi Arabia NA 36/171

(21.0%) 36/171

(21.0%) - - - 6

AlSulaiman Saudi Arabia Yes 265/560

(47.0%) 265/560

(47.0%) - - - 7

Barry Saudi Arabia Yes 17/605

(36.0%) 73/160

(45.6.0%) 1/1

(100.0%) - 64/75

(87.7%) 8

Patel United

Kingdom Yes 268/633

(43.3%) 268/633

(43.3%) - - 268/633

(43.3%) 8

Cueto-

Manzano Mexico No 386/1010

(38.2%) 123/217

(57.0%) - 49/59

(83.0%) 254/298

(85.0%) 6

Carboni

Bisso Argentina Yes 42/168

(27.4%) 42/168

(25.0%) 3/6

(50.0%) - - 8

Islam Bangladesh Yes 135/174

(77.6%) 135/174

(77.6%) - - - 6

Mehdi Iran Yes 295/2351

(12.5%) 147/228

(64.5%) - - - 8

Bergman Sweden No 2844/16083

(17.7%) 565/2494

(22.7%) - - - 8

Tyagi India No - 52/140

(37.1%) - - - 7

Cordova Argentina No 89/809

(11.0%) 52/142

(36.6%) - - 49/97

(50.5%) 8

Kurtz Brazil No 1814/13301

(14.0%) 1814/13301

(14.0%) - - 1042/1765

(59.0%) 6

Estenssoro Argentina Yes 1101/1909

(57.7%) 1101/1909

(57.7%) - 282/373

(25.6%) 1101/1909

(57.7%) 8

(7)

7

Zha Japan Yes 58/205

(28.3%) 58/205

(28.3%) 10/32

(31.3%) - - 8

Martinot France Yes 26/205

(12.7%) 10/31

(4.9%) - - - 8

Khamis Oman Yes 257/1002

(26.0%) 199/473

(42.0%) - - 201/413

(48.7%) 8

Verma India Yes 17/120

(14.2%) 17/120

(14.2%) - - - 8

Castro Brazil No 160495/

522167 (30.7%)

89264/

172473 (51.8%)

- - 66652/

75915 (41.5%)

7

Sharma Nepal Yes 79/94

(84.0% 79/94

(84.0%) - - 79/94

(84.0%) 8

Elhadi Libya Yes 281/465

(60.4%) 281/465

(60.4%) - - 48/54

(17.1%) 8

El-Hamshari Palestine Yes 41/334

(12.3%) 30/99

(30.3%) - - 13/16

(81.3%) 7

Khalid Saudi Arabia Yes 32/101

(31.7%) 32/101

(31.7%) - 14/18

(44.0%) 30/55

(54.5%) 8

Olanipekun United

States Yes 71/220

(32.3%) 71/220

(32.3%) - - 71/220

(32.3%) 4

Routsi Greece No 100/262

(38.0%) 100/262

(38.0%) - - - 6

Dennis United

Kingdom - - 5119/15526

(32.9%) - - - 5

Gonzalez Spain Yes 67/205

(32.7%) 67/205

(32.7%) - - 67/205

(32.7%) 8

Rosenberger Austria No 38/260

(14.6%) 7/13

(53.8%) - - - 3

Mayerhofer Austria Yes 158/508

(31.1%) 158/508

(31.1%) - - - 8

Corrêa Brazil Yes 170/1296

(13.6%) 170/1296

(13.6%) -

(55.0%) 76/151

(50.3%) - 7

Karagiannidis Germany Yes 9066/17023

(53.3%) 9066/17023

(53.3%) - - 3874/7234

(53.5%) 6

Umeh United

States Yes 195/1116

(81.9%) 195/1116

(81.9%) - - - 8

Carbonell Andorra, Ireland,

Spain

Yes 1234/3795

(32.5%) 1234/3795

(32.5%) - - 741/2486

(28.2%) 8

Taxbro Sweden No 43/264

(16.3%) 43/264

(16.3%) - - 25/204

(12.4%) 5

Doidge (a) England, Wales, &

Northern Ireland

NA 1068/2451

(43.6%) 1068/2451

(43.6%) - - - 8

Doidge (b) England, Wales, and

Northern Ireland

Yes 1900/4624

(41.4%) 1900/4624

(41.4%) - - - 7

Kerai India Yes 141/263

(53.6%) 141/263

(53.6%) - - - 8

Dongelmans Netherlands No 3377/12030

(28.1%) 3377/12030

(28.1%) - - - 8

(8)

8

Doidge (c) England, Wales, and

Northern Ireland

Yes 1227/3666

(33.6%) 1227/3666

(33.6%) - - - 8

Murthy Canada Yes 166/811

(20.5%) 86/328

(26.2%) 9/13

(69.2%) 23/49

(46.9%) 91/291

(31.2%) 8

(9)

9 Table S2: Results stratified by incomplete and complete follow-up data

Outcome

Meta-analysis Summary

Without Follow-up Data With Follow-up Data Heterogeneity Test Between Subgroups Rate (%) 95% CI Rate (%) 95% CI p-value In-Hospital Death 22.8 20.5, 25.2 27.9 24.4, 31.6 0.018

ICU Death 32.2 27.3, 37.2 41.2 37.2, 45.2 0.006 MV Death 44.0 31.6, 56.7 56.8 49.8, 63.8 0.082 RRT Death 59.2 47.8, 70.1 69.8 61.8, 77.2 0.087 ECMO Death 59.6 33.5, 83.7 55.9 42.7, 68.8 0.818

Table S3: Results stratified by enrollment end year Outcome

Meta-analysis Summary

2020 2021 Heterogeneity

Test Between Subgroups Rate (%) 95% CI Rate (%) 95% CI p-value In-Hospital Death 25.3 23.4, 27.3 31.4 24.5, 38.6 0.102

ICU Death 37.4 34.3, 40.5 36.6 29.8, 43.7 0.839 MV Death 52.7 47.5, 58.0 31.3 16.1, 48.9 0.023 RRT Death 66.7 60.1, 73.0 50.3 42.4, 58.2 0.003

ECMO Death 58.0 46.9, 68.9 - - -

Table S4: Results stratified by study quality rating Outcome

Meta-analysis Summary

Newcastle-Ottawa Scale – Quality Assessment

Good Poor Heterogeneity

Test Between Subgroups Rate (%) 95% CI Rate (%) 95% CI p-value In-Hospital Death 26.9 24.8, 29.1 25.5 20.2, 31.2 0.655

ICU Death 39.5 36.4, 42.5 33.0 27.7, 38.6 0.047

MV Death 54.1 47.6, 60.5 46.0 39.3, 52.8 0.092

RRT Death 65.4 58.2, 72.3 72.0 58.2, 84.3 0.580

ECMO Death 53.1 41.1, 65.0 74.0 47.7, 94.6 0.169

(10)

10 Table S5: Outcomes based on country

Country In-Hospital

Death ICU Death MV Death RRT Death ECMO Death

Argentina 29.6 (3.4, 67.3) 39.4 (19.5, 61.5) 57.4 (55.2, 59.5) 75.6 (71.0, 79.7) 50.0 (18.8, 81.2) Australia 14.7 (10.5, 20.2) 14.7 (10.5, 20.2) 21.8 (15.4, 30.1) 34.8 (18.8, 55.1)

Austria 25.0 (22.0, 28.2) 27.2 (23.3, 31.3) Bangladesh 77.6 (70.8, 83.1) 67.7 (62.6, 72.6)

Brazil 25.0 (18.3, 32.3) 34.8 (20.2, 51.0) 73.3 (66.1, 80.0) 52.0 (43.8, 60.1) Cameroon 32.3 (27.1, 37.9) 41.8 (32.2, 52.0) 83.3 (43.6, 97.0)

Canada 19.7 (17.3, 22.2) 19.9 (13.1, 27.6) 24.1 (15.9, 33.4) 44.6 (32.4, 57.1) 69.2 (42.4, 87.3) China 15.9 (06.7, 28.0) 34.3 (25.1, 44.0) 73.8 (52.3, 90.9) 78.9 (28.8, 100.0) 72.3 (45.3, 93.8) Colombia 22.5 (18.6, 27.0) 46.2 (38.6, 54.0) 59.3 (50.5, 67.6)

Democratic

Republic of Congo 13.2 (11.0, 15.8) 45.0 (38.1, 52.1)

Denmark 31.8 (25.6, 38.4) 36.9 (28.9, 45.2) 63.0 (44.2, 78.5) 65.5 (54.8, 74.8)

Egypt 24.4 (18.4, 31.6) 24.4 (18.4, 31.6) 84.1 (70.6, 92.1) 71.4 (45.4, 88.3) 100.0 (34.2, 100.0) Finland 16.1 (11.6, 22.0) 13.0 (9.0, 18.5)

France 16.1 (12.5, 20.1) 19.5 (13.6, 26.1) 19.9 (17.1, 23.0) 49.3 (41.0, 57.6) 31.7 (21.6, 44.0) Germany 32.0 (15.3, 51.5) 39.0 (26.8, 52.0) 44.4 (35.5, 53.5) 60.7 (50.7, 70.3) 62.8 (47.5, 77.0) Greece 38.2 (32.5, 44.2) 38.2 (32.5, 44.2)

Guinea 25.0 (18.6, 32.8) 25.0 (18.6, 32.8) India 20.0 (07.9, 35.8) 29.6 (13.3, 49.0)

Iran 20.7 (12.6, 30.2) 54.2 (46.9, 61.4) 1.00.0 (34.2, 100.0) Ireland 16.6 (15.5, 17.7) 20.2 (16.9, 23.8)

Italy 31.8 (19.7, 45.3) 45.4 (28.1, 63.4) 44.4 (35.1, 54.0) 74.1 (61.1, 83.9)

Japan 28.3 (22.6, 34.8) 28.3 (22.6, 34.8) 31.3 (18.0, 48.6)

Kuwait 45.6 (36.3, 55.2) 45.6 (36.3, 55.2) 59.5 (48.5, 69.6) 67.9 (49.3, 82.1) 22.2 (6.3, 54.7) Libya 60.4 (55.9, 64.8) 60.4 (55.9, 64.8) 88.9 (77.8, 94.8)

Mexico 48.6 (20.4, 77.2) 60.2 (51.1, 69.0) 66.5 (51.8, 79.6) 75.8 (65.7, 84.6)

Morocco 31.1 (19.5, 45.7) 78.6 (52.4, 92.4)

Nepal 60.8 (52.2, 68.7) 84.0 (75.3, 90.1) 84.0 (75.3, 90.1) Netherlands 29.3 (25.9, 32.8) 29.6 (23.3, 36.3)

Norway 19.5 (15.9, 23.3) 18.1 (14.7, 21.9) 20.3 (15.2, 26.7) 53.1 (36.4, 69.1) Oman 25.6 (23.0, 28.4) 42.1 (37.7, 46.6) 48.7 (43.9, 53.5)

Pakistan 13.3 (7.7, 20.1) 46.8 (23.9, 70.5) 72.3 (63.2, 80.7) 97.4 (86.5, 99.5) Palestine 12.3 (09.2, 16.2) 30.3 (22.1, 40.0) 81.3 (57.0, 93.4)

Qatar 0.8 (0.5, 1.5) 11.1 (6.5, 18.4) 13.2 (7.7, 21.6)

Saudi Arabia 22.3 (7.4, 42.2) 30.4 (22.3, 39.2) 62.7 (46.4, 77.6) 77.8 (54.8, 91.0) 80.5 (65.6, 92.8) South Korea 42.7 (33.9, 52.1) 42.7 (33.9, 52.1) 45.6 (35.0, 56.5) 66.7 (45.4, 82.8) 42.1 (23.1, 63.7) Spain 30.1 (26.3, 34.1) 36.2 (32.9, 39.7) 38.8 (35.9, 41.8) 73.4 (64.5, 81.7) 61.2 (39.6, 81.3) Sweden 20.0 (17.5, 22.6) 20.0 (17.0, 23.1) 27.2 (24.9, 29.6) 44.6 (38.8, 50.6)

Turkey 26.3 (7.8, 50.7) 52.5 (31.7, 73.0) 75.8 (63.8, 84.8)

United States 30.2 (25.0, 35.6) 49.0 (41.1, 56.9) 49.8 (39.8, 59.8) 70.1 (64.7, 75.2) 46.0 (1.8, 94.3) United Arab Emirates 12.7 (11.1, 14.5) 12.7 (11.1, 14.5) 32.2 (28.3, 36.3)

United Kingdom 33.3 (27.5, 39.4) 34.3 (30.8, 38.0) 29.7 (26.7, 32.9)

(11)

11 Figure S1: Meta-analysis of ICU related mortality

Overall (I^2 = 99.553%, p = 0.000) Chaudhary et al., May 2020 Azoulay et al., Apr 2020

Bhargava et al., Jun 2020

Burrell et al., Jun 2020

Karagiannidis et al., Feb 2021 Chew et al., May 2020

Beatty et al., Jul 2020 Gayam et al., Apr 2020 Mukherjee et al., Apr 2020

Routsi et al., Jan 2021 Dennis et al., Jan 2021 Richards-Belle et al., Mar 2020

Estenssoro et al., Oct 2020 Campanile et al., Jun 2020 Guglielmetti et al., May 2020

Verma et al., Dec 2020 deSouza et al., May 2020

Alkaabi et al., Jul 2020 Akhter et al., Apr 2020

Umeh et al., Mar 2021 Omrani et al., Apr 2020 Kocayigit et al., Apr 2020

Galindo et al., Jun 2020 Zhang et al., Feb 2020

Elhadi et al., Dec 2020 Camporota et al., May 2020 Lei et al., Feb 2020

Cedano et al., Apr 2020 Study

Rodríguez et al., May 2020 Liu et al., Feb 2020

Laake et al., Jun 2020 Cheng et al., Jun 2020

Patel et al., Aug 2020 Janz et al., Apr 2020

Tyagi et al., Oct 2020 Wang et al., Feb 2020

El-Jawahri et al., Apr 2020 Guo et al., Feb 2020

Grasselli et al., Mar 2020

Larsson et al., Apr 2020 Bonnet et al., Apr 2020 Capone et al., Apr 2020 Michela et al., Apr 2020 Chen et al., Mar 2020

Khan et al., Mar 2020

Filardo et al., Apr 2020

Chew (a) et al., May 2020 Cummings et al., Apr 2020

Murthy et al., Jul 2020 Chand et al., Apr 2020

Rieg et al., May 2020 Ñamendys-Silva et al., Apr 2020

AlSulaiman et al., Aug 2020 Docherty et al., Apr 2020

Chew (e) et al., May 2020

Cordova et al., Oct 2020 Kaeuffer et al., Mar 2020

Kim et al., May 2020

Roedl et al., Jun 2020 Haase et al., May 2020 Dosi et al., May 2020 Fleuren et al., Mar 2020

Thomson et al., May 2020

Kayina et al., Jun 2020

Alghamdi et al., Aug 2020 Ayde et al., Apr 2020

Mehdi et al., Sep 2020 Vahedi et al., Jun 2020 Ferrando et al., May 2020 Chew (b) et al., May 2020 Suleyman et al., Mar 2020

Doidge et al., Jul 2021 Peñuelas et al., Apr 2020 Alharthy et al., Mar 2020

Doidge et al., Apr 2021 Feng et al., Feb 2020

ElAidaoui et al., May 2020

Zanella et al., May 2020

El-Hamshari et al., Dec 2020 Shahriarirad et al., Mar 2020

Carrilo-Vega et al., Apr 2020

Estella et al., May 2020 Yang et al., May 2020 Oliveira et al., Mar 2020

Carbonell et al., Mar 2021

Kerai et al., Apr 2021 Wendel Garcia et al., Apr 2020

Rodriguez-Gonzalez et al., Jun 2020 Argenziano et al., Apr 2020

Nachtigall et al., Jun 2020

Kurtz et al., Oct 2020 Bhsrgsvs et al., May 2020 Feng et al., Feb 2020

Zha et al., Nov 2020 Berenguer et al., Mar 2020

DeSouza et al., Aug 2020 Temel et al., Apr 2020

Ferrando-Vivas et al., Jun 2020 Boscolo et al., Apr 2020

Taxbro et al., Mar 2021 Altunal et al., Jun 2020

Donamou et al., Jul 2020 Mitra et al., Apr 2020

Alser et al., Apr 2020

Mekolo et al., May 2020 Cao et al., Feb 2020

Bastug et al., Apr 2020

Sharma et al., Dec 2020 Chew (d) et al., Jun 2020

Khamis et al., Dec 2020 Khan Chachar et al., Jun 2020 Goshayeshi et al., May 2020

Saha et al., Aug 2020 Israelsen et al., Apr 2020

Magunia et al., May 2020

Ñamendys-Silva et al., Aug 2020 Barry et al., Aug 2020 Ahlstrom et al., May 2020

Roger et al., Jul 2020

Cueto-Manzano et al., Sep 2020 Carboni Bisso et al., Sep 2020

Gonzalez et al., Feb 2021 Chen et al., Apr 2020

Hernandez-Romieu et al., May 2020

Islam et al., Sep 2020 Serrano-Martinez et al., May 2020

Olanipekun et al., Dec 2020 Cheng et al., May 2020 Yang et al., Feb 2020

AlMutair et al., Jun 2020

Rosenberger et al., Feb 2021 Nassar et al., Jul 2020

Castro et al., Dec 2020 Jalili et al., Jul 2020 Rodrigo et al., May 2020

Doidge et al., Mar 2021 Gadhiya et al., May 2020 Kim et al., Apr 2020

Alvarez-Maldonado et al., Jul 2020 Huang et al., Feb 2020

Corrêa et al., Feb 2021 Khalid et al., Dec 2020 Wang et al., Feb 2020

Guisado-Vasco et al., Apr 2020

Mayerhofer et al., Feb 2021 Nasir et al., Jun 2020

Nachega et al., Jul 2020 Bidari et al., Apr 2020 Martinot et al., Mar 2020

Bergman et al., Sep 2020

Martinot et al., Nov 2020

Dongelmans et al., Jul 2021 Chen et al., May 2020 Turcotte et al., Apr 2020

Grasselli et al., May 2020

80 97

106

30

9066 361

105 78 82

100 5119 90

1088 55 33

17 7

196 19

195 12 52

73 9

281 7 1

92 deaths

660 157

40 98

268 71

52 133

74 329

405

60 74 61 203 50

12

72

108 101

86 106

33 85

265 958

361

52 26

299

78 108 31 332

38

20

21 47

147 77 203 25 57

1227 335 113

1911 20

14

426

30 5

294

144 18 26

1166

141 97

52 103

109

1446 75 29

58 312

35634 16

3867 120

26 33

35 18

58

38 6

20

79 40

199 37 70

95 16

403

3647 73 346

173

123 42

67 45

56

135 20

71 133 14

459

7 39

89264 56 135

1068 42 47

58 0

170 32 0

24

139 40

86 107 44

565

10

2916 181 17

1769 Total ICU Number of

128 376

140

204

17023 1563

521 117 137

262 15526 200

1909 806 64

120 19

1542 33

238 108 103

158 44

465 213 36

132 patients

2022 349

217 211

633 147

140 344

178 733

1581

260 475 102 553 192

77

135

323 257

328 300

70 164

560 3001

1563

142 335

798

223 323 83 1152

156

235

171 103

228 133 663 192 141

3666 868 352

4624 29

45

1260

99 11

486

422 106 131

3795

263 639

126 236

399

13301 101 70

205 736

57103 53

9990 120

264 39

140 117

235

91 18

46

94 224

473 137 151

168 27

1186

5090 160 1981

966

217 168

205 135

284

174 59

220 268 29

1470

13 160

172473 125 300

2450 89 110

100 11

1296 101 29

49

508 68

191 186 153

2494

31

12030 228 36

3988 of ICU Number

0.373 (0.346, 0.401) 0.625 (0.539, 0.704) 0.258 (0.216, 0.304)

0.757 (0.680, 0.821)

0.147 (0.105, 0.202)

0.533 (0.525, 0.540) 0.231 (0.211, 0.253)

0.202 (0.169, 0.238) 0.667 (0.577, 0.746) 0.599 (0.515, 0.677)

0.382 (0.325, 0.442) 0.330 (0.322, 0.337) 0.450 (0.383, 0.519)

0.570 (0.548, 0.592) 0.068 (0.053, 0.088) 0.516 (0.396, 0.634)

0.142 (0.090, 0.215) 0.368 (0.191, 0.590)

0.127 (0.111, 0.145) 0.576 (0.408, 0.728)

0.819 (0.766, 0.863) 0.111 (0.065, 0.184) 0.505 (0.410, 0.599)

0.462 (0.386, 0.540) 0.205 (0.112, 0.345)

0.604 (0.559, 0.648) 0.033 (0.016, 0.066) 0.028 (0.005, 0.142)

0.697 (0.614, 0.769) ES (95% CI)

0.326 (0.306, 0.347) 0.450 (0.398, 0.502)

0.184 (0.138, 0.241) 0.464 (0.398, 0.532)

0.423 (0.385, 0.462) 0.483 (0.404, 0.563)

0.371 (0.296, 0.454) 0.387 (0.337, 0.439)

0.416 (0.346, 0.489) 0.449 (0.413, 0.485)

0.256 (0.235, 0.278)

0.231 (0.184, 0.286) 0.156 (0.126, 0.191) 0.598 (0.501, 0.688) 0.367 (0.328, 0.408) 0.260 (0.203, 0.327)

0.156 (0.091, 0.253)

0.533 (0.449, 0.615)

0.334 (0.285, 0.387) 0.393 (0.335, 0.454)

0.262 (0.218, 0.312) 0.353 (0.301, 0.409)

0.471 (0.359, 0.587) 0.518 (0.442, 0.593)

0.473 (0.432, 0.515) 0.319 (0.303, 0.336)

0.231 (0.211, 0.253)

0.366 (0.291, 0.448) 0.078 (0.054, 0.111)

0.375 (0.342, 0.409)

0.350 (0.290, 0.414) 0.334 (0.285, 0.387) 0.373 (0.277, 0.481) 0.288 (0.263, 0.315)

0.244 (0.183, 0.317)

0.085 (0.056, 0.128)

0.123 (0.082, 0.180) 0.456 (0.363, 0.552)

0.645 (0.581, 0.704) 0.579 (0.494, 0.659) 0.306 (0.272, 0.342) 0.130 (0.090, 0.185) 0.404 (0.327, 0.487)

0.335 (0.320, 0.350) 0.386 (0.354, 0.419) 0.321 (0.274, 0.372)

0.413 (0.399, 0.428) 0.690 (0.508, 0.827)

0.311 (0.195, 0.457)

0.338 (0.313, 0.365)

0.303 (0.221, 0.400) 0.455 (0.213, 0.720)

0.605 (0.561, 0.647)

0.341 (0.298, 0.388) 0.170 (0.110, 0.253) 0.198 (0.139, 0.275)

0.307 (0.293, 0.322)

0.536 (0.476, 0.595) 0.152 (0.126, 0.182)

0.413 (0.331, 0.500) 0.436 (0.375, 0.500)

0.273 (0.232, 0.319)

0.109 (0.104, 0.114) 0.743 (0.650, 0.818) 0.414 (0.306, 0.531)

0.283 (0.226, 0.348) 0.424 (0.389, 0.460)

0.624 (0.620, 0.628) 0.302 (0.195, 0.435)

0.387 (0.378, 0.397) 1.000 (0.969, 1.000)

0.098 (0.068, 0.140) 0.846 (0.703, 0.928)

0.250 (0.186, 0.328) 0.154 (0.100, 0.230)

0.247 (0.196, 0.306)

0.418 (0.322, 0.520) 0.333 (0.163, 0.563)

0.435 (0.302, 0.578)

0.840 (0.753, 0.901) 0.179 (0.134, 0.234)

0.421 (0.377, 0.466) 0.270 (0.203, 0.350) 0.464 (0.386, 0.543)

0.565 (0.490, 0.638) 0.593 (0.407, 0.755)

0.340 (0.313, 0.367)

0.717 (0.704, 0.729) 0.456 (0.381, 0.534) 0.175 (0.159, 0.192)

0.179 (0.156, 0.205)

0.567 (0.500, 0.631) 0.250 (0.191, 0.321)

0.327 (0.266, 0.394) 0.333 (0.259, 0.416)

0.197 (0.155, 0.247)

0.776 (0.708, 0.831) 0.339 (0.231, 0.466)

0.323 (0.264, 0.387) 0.496 (0.437, 0.556) 0.483 (0.314, 0.656)

0.312 (0.289, 0.336)

0.538 (0.291, 0.768) 0.244 (0.184, 0.316)

0.518 (0.515, 0.520) 0.448 (0.364, 0.535) 0.450 (0.395, 0.507)

0.436 (0.416, 0.456) 0.472 (0.372, 0.575) 0.427 (0.339, 0.521)

0.580 (0.482, 0.672) 0.000 (0.000, 0.259)

0.131 (0.114, 0.151) 0.317 (0.234, 0.413) 0.000 (0.000, 0.117)

0.490 (0.356, 0.625)

0.274 (0.237, 0.314) 0.588 (0.470, 0.697)

0.450 (0.381, 0.521) 0.575 (0.503, 0.644) 0.288 (0.222, 0.364)

0.227 (0.211, 0.243)

0.323 (0.186, 0.499)

0.242 (0.235, 0.250) 0.794 (0.737, 0.841) 0.472 (0.320, 0.630)

0.444 (0.428, 0.459)

100.00 0.65 0.67

0.65

0.66

0.69 0.68

0.68 0.64 0.65

0.67 0.69 0.66

0.68 0.68 0.61

0.64 0.48

0.68 0.55

0.66 0.64 0.64

0.65 0.58

0.68 0.66 0.56

0.65 Weight

0.68 0.67

0.66 0.66

0.68 0.65

0.65 0.67

0.66 0.68

0.68

0.67 0.68 0.64 0.68 0.66

0.62

0.65

0.67 0.67

0.67 0.67

0.62 0.65

0.68 0.69

0.68

0.65 0.67

0.68

0.66 0.67 0.63 0.68

0.65

0.66

0.66 0.64

0.66 0.65 0.68 0.66 0.65

0.69 0.68 0.67

0.69 0.54

0.58

0.68

0.63 0.40

0.68

0.67 0.64 0.65

0.69

0.67 0.68

0.65 0.66

0.67

0.69 0.64 0.62

0.66 0.68

0.69 0.60

0.69 0.64

0.67 0.57

0.65 0.64

0.66

0.63 0.48

0.58

0.63 0.66

0.68 0.65 0.65

0.65 0.53

0.68

0.69 0.65 0.68

0.68

0.66 0.65

0.66 0.65

0.67

0.66 0.60

0.66 0.67 0.54

0.68

0.43 0.65

0.69 0.64 0.67

0.68 0.63 0.64

0.63 0.40

0.68 0.64 0.54

0.59

0.68 0.61

0.66 0.66 0.65

0.68

0.54

0.69 0.66 0.56

0.69

%

0.373 (0.346, 0.401) 0.625 (0.539, 0.704) 0.258 (0.216, 0.304)

0.757 (0.680, 0.821)

0.147 (0.105, 0.202)

0.533 (0.525, 0.540) 0.231 (0.211, 0.253)

0.202 (0.169, 0.238) 0.667 (0.577, 0.746) 0.599 (0.515, 0.677)

0.382 (0.325, 0.442) 0.330 (0.322, 0.337) 0.450 (0.383, 0.519)

0.570 (0.548, 0.592) 0.068 (0.053, 0.088) 0.516 (0.396, 0.634)

0.142 (0.090, 0.215) 0.368 (0.191, 0.590)

0.127 (0.111, 0.145) 0.576 (0.408, 0.728)

0.819 (0.766, 0.863) 0.111 (0.065, 0.184) 0.505 (0.410, 0.599)

0.462 (0.386, 0.540) 0.205 (0.112, 0.345)

0.604 (0.559, 0.648) 0.033 (0.016, 0.066) 0.028 (0.005, 0.142)

0.697 (0.614, 0.769) ES (95% CI)

0.326 (0.306, 0.347) 0.450 (0.398, 0.502)

0.184 (0.138, 0.241) 0.464 (0.398, 0.532)

0.423 (0.385, 0.462) 0.483 (0.404, 0.563)

0.371 (0.296, 0.454) 0.387 (0.337, 0.439)

0.416 (0.346, 0.489) 0.449 (0.413, 0.485)

0.256 (0.235, 0.278)

0.231 (0.184, 0.286) 0.156 (0.126, 0.191) 0.598 (0.501, 0.688) 0.367 (0.328, 0.408) 0.260 (0.203, 0.327)

0.156 (0.091, 0.253)

0.533 (0.449, 0.615)

0.334 (0.285, 0.387) 0.393 (0.335, 0.454)

0.262 (0.218, 0.312) 0.353 (0.301, 0.409)

0.471 (0.359, 0.587) 0.518 (0.442, 0.593)

0.473 (0.432, 0.515) 0.319 (0.303, 0.336)

0.231 (0.211, 0.253)

0.366 (0.291, 0.448) 0.078 (0.054, 0.111)

0.375 (0.342, 0.409)

0.350 (0.290, 0.414) 0.334 (0.285, 0.387) 0.373 (0.277, 0.481) 0.288 (0.263, 0.315)

0.244 (0.183, 0.317)

0.085 (0.056, 0.128)

0.123 (0.082, 0.180) 0.456 (0.363, 0.552)

0.645 (0.581, 0.704) 0.579 (0.494, 0.659) 0.306 (0.272, 0.342) 0.130 (0.090, 0.185) 0.404 (0.327, 0.487)

0.335 (0.320, 0.350) 0.386 (0.354, 0.419) 0.321 (0.274, 0.372)

0.413 (0.399, 0.428) 0.690 (0.508, 0.827)

0.311 (0.195, 0.457)

0.338 (0.313, 0.365)

0.303 (0.221, 0.400) 0.455 (0.213, 0.720)

0.605 (0.561, 0.647)

0.341 (0.298, 0.388) 0.170 (0.110, 0.253) 0.198 (0.139, 0.275)

0.307 (0.293, 0.322)

0.536 (0.476, 0.595) 0.152 (0.126, 0.182)

0.413 (0.331, 0.500) 0.436 (0.375, 0.500)

0.273 (0.232, 0.319)

0.109 (0.104, 0.114) 0.743 (0.650, 0.818) 0.414 (0.306, 0.531)

0.283 (0.226, 0.348) 0.424 (0.389, 0.460)

0.624 (0.620, 0.628) 0.302 (0.195, 0.435)

0.387 (0.378, 0.397) 1.000 (0.969, 1.000)

0.098 (0.068, 0.140) 0.846 (0.703, 0.928)

0.250 (0.186, 0.328) 0.154 (0.100, 0.230)

0.247 (0.196, 0.306)

0.418 (0.322, 0.520) 0.333 (0.163, 0.563)

0.435 (0.302, 0.578)

0.840 (0.753, 0.901) 0.179 (0.134, 0.234)

0.421 (0.377, 0.466) 0.270 (0.203, 0.350) 0.464 (0.386, 0.543)

0.565 (0.490, 0.638) 0.593 (0.407, 0.755)

0.340 (0.313, 0.367)

0.717 (0.704, 0.729) 0.456 (0.381, 0.534) 0.175 (0.159, 0.192)

0.179 (0.156, 0.205)

0.567 (0.500, 0.631) 0.250 (0.191, 0.321)

0.327 (0.266, 0.394) 0.333 (0.259, 0.416)

0.197 (0.155, 0.247)

0.776 (0.708, 0.831) 0.339 (0.231, 0.466)

0.323 (0.264, 0.387) 0.496 (0.437, 0.556) 0.483 (0.314, 0.656)

0.312 (0.289, 0.336)

0.538 (0.291, 0.768) 0.244 (0.184, 0.316)

0.518 (0.515, 0.520) 0.448 (0.364, 0.535) 0.450 (0.395, 0.507)

0.436 (0.416, 0.456) 0.472 (0.372, 0.575) 0.427 (0.339, 0.521)

0.580 (0.482, 0.672) 0.000 (0.000, 0.259)

0.131 (0.114, 0.151) 0.317 (0.234, 0.413) 0.000 (0.000, 0.117)

0.490 (0.356, 0.625)

0.274 (0.237, 0.314) 0.588 (0.470, 0.697)

0.450 (0.381, 0.521) 0.575 (0.503, 0.644) 0.288 (0.222, 0.364)

0.227 (0.211, 0.243)

0.323 (0.186, 0.499)

0.242 (0.235, 0.250) 0.794 (0.737, 0.841) 0.472 (0.320, 0.630)

0.444 (0.428, 0.459)

100.00 0.65 0.67

0.65

0.66

0.69 0.68

0.68 0.64 0.65

0.67 0.69 0.66

0.68 0.68 0.61

0.64 0.48

0.68 0.55

0.66 0.64 0.64

0.65 0.58

0.68 0.66 0.56

0.65 Weight

0.68 0.67

0.66 0.66

0.68 0.65

0.65 0.67

0.66 0.68

0.68

0.67 0.68 0.64 0.68 0.66

0.62

0.65

0.67 0.67

0.67 0.67

0.62 0.65

0.68 0.69

0.68

0.65 0.67

0.68

0.66 0.67 0.63 0.68

0.65

0.66

0.66 0.64

0.66 0.65 0.68 0.66 0.65

0.69 0.68 0.67

0.69 0.54

0.58

0.68

0.63 0.40

0.68

0.67 0.64 0.65

0.69

0.67 0.68

0.65 0.66

0.67

0.69 0.64 0.62

0.66 0.68

0.69 0.60

0.69 0.64

0.67 0.57

0.65 0.64

0.66

0.63 0.48

0.58

0.63 0.66

0.68 0.65 0.65

0.65 0.53

0.68

0.69 0.65 0.68

0.68

0.66 0.65

0.66 0.65

0.67

0.66 0.60

0.66 0.67 0.54

0.68

0.43 0.65

0.69 0.64 0.67

0.68 0.63 0.64

0.63 0.40

0.68 0.64 0.54

0.59

0.68 0.61

0.66 0.66 0.65

0.68

0.54

0.69 0.66 0.56

0.69

%

0 .2 .4 .6 .8 1

Proportion

(12)

12 Figure S2: Meta-analysis of mechanical ventilation related mortality

Overall (I^2 = 99.676%, p = 0.000) Feng et al., Feb 2020

Galindo et al., Jun 2020 Liu et al., Feb 2020

Sharma et al., Dec 2020 Murthy et al., Jul 2020 Zanella et al., May 2020 Yang et al., May 2020

Nachtigall et al., Jun 2020 Ferrando et al., May 2020

Cordova et al., Oct 2020 Israelsen et al., Apr 2020

Elhadi et al., Dec 2020 Kocayigit et al., Apr 2020 Zhou et al., Apr 2020

Cueto-Manzano et al., Sep 2020 Burrell et al., Jun 2020 Study

Mekolo et al., May 2020 Boscolo et al., Apr 2020 Kim et al., Apr 2020

Ayde et al., Apr 2020 Wendel Garcia et al., Apr 2020 Argenziano et al., Apr 2020

Kim et al., May 2020

Rodríguez et al., May 2020 Chew et al., May 2020 El-Jawahri et al., Apr 2020

Roger et al., Jul 2020 Mitra et al., Apr 2020 Oliveira et al., Mar 2020

Gonzalez et al., Feb 2021 Gadhiya et al., May 2020

Karagiannidis et al., Feb 2021 Filardo et al., Apr 2020

ElAidaoui et al., May 2020

Patel et al., Aug 2020 Camporota et al., May 2020 Gayam et al., Apr 2020

DeSouza et al., Aug 2020 Magunia et al., May 2020 Serrano-Martinez et al., May 2020

Laake et al., Jun 2020 Roedl et al., Jun 2020

Alkaabi et al., Jul 2020 Hernandez-Romieu et al., May 2020

Nassar et al., Jul 2020 Wang et al., Feb 2020

Khan Chachar et al., Jun 2020 Grasselli et al., May 2020 Cummings et al., Apr 2020

Peñuelas et al., Apr 2020

Taxbro et al., Mar 2021 Ñamendys-Silva et al., Apr 2020 Wang et al., Feb 2020 Berenguer et al., Mar 2020

Carbonell et al., Mar 2021 Estella et al., May 2020

Barry et al., Aug 2020 Ñamendys-Silva et al., Aug 2020 Rodriguez-Gonzalez et al., Jun 2020

Kurtz et al., Oct 2020

El-Hamshari et al., Dec 2020 Olanipekun et al., Dec 2020 Castro et al., Dec 2020 Nasir et al., Jun 2020

AlMutair et al., Jun 2020

Estenssoro et al., Oct 2020

Khalid et al., Dec 2020 Omrani et al., Apr 2020

Chaudhary et al., May 2020 Shahriarirad et al., Mar 2020

Chen et al., May 2020 Carrilo-Vega et al., Apr 2020 Cao et al., Feb 2020

Rodrigo et al., May 2020

Khamis et al., Dec 2020 Rieg et al., May 2020 Alharthy et al., Mar 2020

18

73 36

79 91 272 12

77 182

49 among MV

17

48 Number

47 56

254 26 patients

5 120 36

4758 111

246

458 368 73

143 15 of deaths

26

67 33

3874 67

11

268 7 92

28145 217 23

38 74

167 63

37 0

37 1514 151

335

25 85 97 283

741 146

64 8861 47

1042

13 71 66652 36

508

1101

30 12

4 2

90 234 12

127

201 29 86

22

123 42

94 291 707 65

250 494

97 patients who

27

54 62 97

298 119 received MV

6 280 79

79317 233

462

1174 1222 150

719 74 Number of

109

205 58

7235 121

14

633 213 117

33916 495 49

187 167

519 175

44 11

40 2929 203

868

204 164 100 619

2486 422

75 12018 113

1765

16 220 75915 64

778

1909

55 91

12 2

103 460 14

227

413 57 200

0.516 (0.461, 0.570) 0.818 (0.615, 0.927)

0.593 (0.505, 0.676) 0.857 (0.722, 0.933)

0.840 (0.753, 0.901) 0.313 (0.262, 0.368) 0.385 (0.350, 0.421) 0.185 (0.109, 0.296)

0.308 (0.254, 0.368) 0.368 (0.327, 0.412)

0.505 (0.407, 0.603) 0.630 (0.442, 0.785)

0.889 (0.778, 0.948) 0.758 (0.638, 0.848) 0.577 (0.478, 0.671)

0.852 (0.808, 0.888) 0.218 (0.154, 0.301) ES (95% CI)

0.833 (0.436, 0.970) 0.429 (0.372, 0.487) 0.456 (0.350, 0.565)

0.595 (0.485, 0.696) 0.183 (0.144, 0.229) 0.476 (0.413, 0.540)

0.532 (0.487, 0.578)

0.390 (0.363, 0.418) 0.301 (0.276, 0.327) 0.487 (0.408, 0.566)

0.199 (0.171, 0.230) 0.203 (0.127, 0.308) 0.239 (0.168, 0.327)

0.327 (0.266, 0.394) 0.569 (0.441, 0.688)

0.535 (0.524, 0.547) 0.554 (0.465, 0.639)

0.786 (0.524, 0.924)

0.423 (0.385, 0.462) 0.033 (0.016, 0.066) 0.786 (0.704, 0.851)

0.830 (0.826, 0.834) 0.438 (0.395, 0.482) 0.469 (0.337, 0.606)

0.203 (0.152, 0.267) 0.443 (0.370, 0.519)

0.322 (0.283, 0.363) 0.360 (0.293, 0.433)

0.841 (0.706, 0.921) 0.000 (0.000, 0.259)

0.925 (0.801, 0.974) 0.517 (0.499, 0.535) 0.744 (0.680, 0.799)

0.386 (0.354, 0.419)

0.123 (0.084, 0.175) 0.518 (0.442, 0.593) 0.970 (0.915, 0.990) 0.457 (0.418, 0.497)

0.298 (0.280, 0.316) 0.346 (0.302, 0.393)

0.853 (0.756, 0.916) 0.737 (0.729, 0.745) 0.416 (0.329, 0.508)

0.590 (0.567, 0.613)

0.813 (0.570, 0.934) 0.323 (0.264, 0.387) 0.878 (0.876, 0.880) 0.563 (0.441, 0.677)

0.653 (0.619, 0.686)

0.577 (0.554, 0.599)

0.545 (0.415, 0.670) 0.132 (0.077, 0.216)

0.333 (0.138, 0.609) 1.000 (0.342, 1.000)

0.874 (0.796, 0.925) 0.509 (0.463, 0.554) 0.857 (0.601, 0.960)

0.559 (0.494, 0.623)

0.487 (0.439, 0.535) 0.509 (0.383, 0.634) 0.430 (0.363, 0.499)

100.00 1.15

1.33 1.25

1.32 1.36 1.38 1.29

1.36 1.37

1.32

%

1.18

1.28 1.29 1.32

1.36 1.33 Weight

0.81 1.36 1.31

1.31 1.36 1.36

1.37

1.38 1.38 1.34

1.38 1.30 1.33

1.35 1.28

1.38 1.33

1.05

1.37 1.35 1.33

1.38 1.37 1.27

1.35 1.35

1.37 1.35

1.25 0.99

1.24 1.38 1.35

1.38

1.35 1.35 1.32 1.37

1.38 1.37

1.30 1.38 1.33

1.38

1.08 1.36 1.38 1.29

1.38

1.38

1.28 1.32

1.01 0.49

1.33 1.37 1.05

1.36

1.37 1.28 1.35

0.516 (0.461, 0.570) 0.818 (0.615, 0.927)

0.593 (0.505, 0.676) 0.857 (0.722, 0.933)

0.840 (0.753, 0.901) 0.313 (0.262, 0.368) 0.385 (0.350, 0.421) 0.185 (0.109, 0.296)

0.308 (0.254, 0.368) 0.368 (0.327, 0.412)

0.505 (0.407, 0.603) 0.630 (0.442, 0.785)

0.889 (0.778, 0.948) 0.758 (0.638, 0.848) 0.577 (0.478, 0.671)

0.852 (0.808, 0.888) 0.218 (0.154, 0.301) ES (95% CI)

0.833 (0.436, 0.970) 0.429 (0.372, 0.487) 0.456 (0.350, 0.565)

0.595 (0.485, 0.696) 0.183 (0.144, 0.229) 0.476 (0.413, 0.540)

0.532 (0.487, 0.578)

0.390 (0.363, 0.418) 0.301 (0.276, 0.327) 0.487 (0.408, 0.566)

0.199 (0.171, 0.230) 0.203 (0.127, 0.308) 0.239 (0.168, 0.327)

0.327 (0.266, 0.394) 0.569 (0.441, 0.688)

0.535 (0.524, 0.547) 0.554 (0.465, 0.639)

0.786 (0.524, 0.924)

0.423 (0.385, 0.462) 0.033 (0.016, 0.066) 0.786 (0.704, 0.851)

0.830 (0.826, 0.834) 0.438 (0.395, 0.482) 0.469 (0.337, 0.606)

0.203 (0.152, 0.267) 0.443 (0.370, 0.519)

0.322 (0.283, 0.363) 0.360 (0.293, 0.433)

0.841 (0.706, 0.921) 0.000 (0.000, 0.259)

0.925 (0.801, 0.974) 0.517 (0.499, 0.535) 0.744 (0.680, 0.799)

0.386 (0.354, 0.419)

0.123 (0.084, 0.175) 0.518 (0.442, 0.593) 0.970 (0.915, 0.990) 0.457 (0.418, 0.497)

0.298 (0.280, 0.316) 0.346 (0.302, 0.393)

0.853 (0.756, 0.916) 0.737 (0.729, 0.745) 0.416 (0.329, 0.508)

0.590 (0.567, 0.613)

0.813 (0.570, 0.934) 0.323 (0.264, 0.387) 0.878 (0.876, 0.880) 0.563 (0.441, 0.677)

0.653 (0.619, 0.686)

0.577 (0.554, 0.599)

0.545 (0.415, 0.670) 0.132 (0.077, 0.216)

0.333 (0.138, 0.609) 1.000 (0.342, 1.000)

0.874 (0.796, 0.925) 0.509 (0.463, 0.554) 0.857 (0.601, 0.960)

0.559 (0.494, 0.623)

0.487 (0.439, 0.535) 0.509 (0.383, 0.634) 0.430 (0.363, 0.499)

100.00 1.15

1.33 1.25

1.32 1.36 1.38 1.29

1.36 1.37

1.32

%

1.18

1.28 1.29 1.32

1.36 1.33 Weight

0.81 1.36 1.31

1.311.36 1.36

1.37

1.38 1.38 1.34

1.38 1.30 1.33

1.35 1.28

1.38 1.33

1.05

1.37 1.35 1.33

1.38 1.37 1.27

1.35 1.35

1.37 1.35

1.25 0.99

1.24 1.38 1.35

1.38

1.35 1.35 1.32 1.37

1.38 1.37

1.30 1.38 1.33

1.38

1.08 1.36 1.38 1.29

1.38

1.38

1.28 1.32

1.01 0.49

1.33 1.37 1.05

1.36

1.37 1.28 1.35

0 .2 .4 .6 .8 1

Proportion

(13)

13

Figure S3: Funnel plot for bias assessment- In-hospital mortality

(14)

14 Figure S4: Funnel plot for bias asse

Referensi

Dokumen terkait

⇒ Recent systematic reviews identified a potential- ly higher paediatric mortality per population from COVID- 19 in low- income to middle- income coun- tries (LMICs) compared

This study aimed to determine the characteristics, therapy, and outcomes of critically ill COVID-19 patients treated in the ICU.. This was a multicentre retrospective

Covid-19 Related Factors Associated with Antenatal Care in Rural Bangladesh: A qualitative study 1 Asia Pacific Journal of Health Management 2022; 171:i1015.. Department of

Research article Clinical characteristics and risk factors for disease severity and mortality of COVID-19 patients with diabetes mellitus in Kazakhstan: A nationwide study Azhar

To date, most studies regarding the COVID‑19 and associated mortality were reported from developed countries.[12] For example, a study of more than 5000 patients who were infected with

Published by Tehran University of Medical Sciences Identification of Risk Factors Associated With Mortality Among Patients With COVID-19 Using Random Forest Model: A Historical

Several studies have confirmed that the comorbid disease is also strongly related to a higher fatality rate, increased demand for intensive care as well as higher mortality rate among